Morphine is Still the Standard Opioid in the Treatment of Cancer Pain

  • SHIMOYAMA Naohito
    Department of Anesthesiology and Palliative Medicine, National Cancer Center Hospital
  • NAKATA Wakako
    Department of Anesthesiology and Palliative Medicine, National Cancer Center Hospital
  • MURAKAMI Satoshi
    Department of Anesthesiology and Palliative Medicine, National Cancer Center Hospital
  • TAKAHASHI Hidenori
    Department of Anesthesiology and Palliative Medicine, National Cancer Center Hospital
  • NAKAYAMA Rika
    Department of Anesthesiology and Palliative Medicine, National Cancer Center Hospital
  • SHUTOH Mariko
    Department of Anesthesiology and Palliative Medicine, National Cancer Center Hospital
  • SHIMOYAMA Megumi
    Department of Autonomic Physiology, Chiba University Graduate School of Medicine

Bibliographic Information

Other Title
  • モルヒネは現在でもがん性とう痛治療におけるスタンダードである

Abstract

  Management of pain in cancer patients according to the WHO ladder using morphine is still the standard in treating cancer pain, even after both oxycontin® and fentanyl patch became available in Japan. One reason is that rescue opioids other than morphine are not available. Immediate opioids are useful not only in treating breakthrough pain, but also in assessing whether the cancer pain is refractory to opioids or not. Although opioid rotation is sometimes performed to control side effects, it should be used only after appropriate side effect treatment. If the side effects are well controlled, side effect control with other opioids is much easier.

Journal

References(1)*help

See more

Details 詳細情報について

  • CRID
    1390282679736642304
  • NII Article ID
    130004449523
  • DOI
    10.2199/jjsca.25.526
  • ISSN
    13499149
    02854945
  • Text Lang
    ja
  • Data Source
    • JaLC
    • Crossref
    • CiNii Articles
  • Abstract License Flag
    Disallowed

Report a problem

Back to top